Pricing Log in Create free account
Friday 6 November 2026 Export BIO.B’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

BIO.B Healthcare Medical Devices

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue
+0.52%
EPS
+234.9%
Free cash flow
+8.07%
Total debt
+0.11%

Quarter to September 2026, against a year earlier

379.50 15.35 +4.22%
Market cap
$10.3B
P/E
9.9×
Fwd P/E
—
Dividend yield
—
F-score
5/9
Altman Z
3.24
Beneish M
−2.29
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Rad Laboratories, Inc. (BIO.B) Debt to equity

Alert me on Debt to equity

Bio-Rad Laboratories, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.2×, down 0.0× from fiscal 2025 (0.2×). Over the past ten years it has ranged from 0.0× (fiscal 2021) to 0.2× (fiscal 2024); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.2× (11.76%)
FY2024 0.2× 33.31%
FY2023 0.1× 10.11%
FY2022 0.1× 15,475.00%
FY2021 0.0× (42.86%)
FY2020 0.0× (98.17%)
FY2019 0.1× (30.10%)
FY2018 0.1× (26.40%)
FY2017 0.1× (11.76%)
FY2016 0.2× (3.39%)

Quarterly newest first

Period Debt to equity Change
Sep 2026 0.2× (5.60%)
Jun 2026 0.2× (4.44%)
Mar 2026 0.2× 8.80%
Dec 2025 0.2× (9.58%)
43 more quarters

Against its own ten years

Low 0.0× High 0.2×
Ten-year median 0.1×
Current reading's percentile 73

Debt to equity against peers

Company Debt to equity
GMED Globus Medical, Inc. compare 0.0×
TXG 10x Genomics compare 0.0×
PEN Penumbra, Inc. compare 0.0×
GKOS Glaukos Corporation compare 0.1×
BIO Bio-Rad Laboratories, Inc. compare 0.2×
BIO.B Bio-Rad Laboratories, Inc. 0.2×
PODD Insulet Corporation compare 0.6×
SNN Smith & Nephew SNATS, Inc. compare 0.6×
BRKR Bruker Corporation compare 0.7×
Medical Devices industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on BIO.B